Читать «Микробы хорошие и плохие. Наше здоровье и выживание в мире бактерий» онлайн - страница 220

38 L. Clifford McDonald et al., “An Epidemic, Toxin Gene-Variant Strain of Clostridium difficile”, New England Journal of Medicine 353 (2005), 2433–2441.

39 Carlene Muto et al., “A Large Outbreak of Clostridium difficile – Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use”, Infection Control Hospital Epidemiology 3 (2005), 273–280.

40 Luis Fabregas, “Superbug Infecting Area Patients”, Pittsburgh Tribune-Review, October 29, 2005.

41 “Severe Clostridium difficile Associated Disease in Populations Previously at Low Risk – Four States, 2005”, Morbidity and Mortality Weekly Report, December 2, 2005.

42 Yves Gillet et al., “Association Between Staphylococcus aureus Strains Carrying Gene for Panton-Valentine Leukocidin and Highly Lethal Necrotising Pneumonia in Young Immunocompetent Patients”, Lancet 359 (2002), 753–759.

43 Айзек Старр (Isaac Starr), в 1918 г. – студент-медик третьего курса Пенсильванского университета, цитируется по статье: “Influenza in 1918: Recollection of the Epidemic in Philadelphia”, Annals of Internal Medicine 145 (2006), 138–140.

44 Betsy Herold et al., “Community-Acquired Methicillin-Resistant Staphylococcus aureus in Children with No Identified Predisposing Risk”, Journal of the American Medical Association 279 (1998), 593–598.

45 “Four Pediatric Deaths from Community-Acquired Methicillin-Resistant Staphylococcus aureus – Minnesota and North Dakota, 1997–1999”, Morbidity and Mortality Weekly Report, August 20, 1999, 707–710.

46 Carlos Sattler et al., “Prospective Comparison of Risk Factors and Demographic and Clinical Characteristics of Community-Acquired, Methicillin-Resistant versus Methicillin-Susceptible Staphylococcus aureus Infection in Children”, Pediatric Infectious Disease Journal 21 (2002), 910–916.

47 Sophia Kazakova et al., “A Clone of Methicillin-Resistant Staphylococcus aureus Among Professional Football Players”, New England Journal of Medicine 352 (2005), 468–475.

48 D. A. Robinson et al., “Re-emergence of Early Pandemic Staphylococcus aureus as a Community-Acquired Methicillin-Resistant Clone”, Lancet 365 (2005), 1256–1258.

49 Sheldon Kaplan et al., “Three-year Surveillance of Community-Acquired Staphylococcus aureus Infections in Children”, Clinical Infectious Diseases 40 (2005), 1785–1791; M. D. King et al., “Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 30 °Clone as the Predominant Cause of Skin and Soft-Tissue Infections”, Annals of Internal Medicine 144 (2006), 309–317; Gregory Moran et al, “Methicillin-Resistant S. aureus Infections Among Patients in the Emergency Department”, New England Journal of Medicine 355 (2006), 666–674.

50 Tsutomu Watanabe et al., “Episome-Mediated Transfer of Drug Resistance in Enterobacteriaceae X”, Journal of Bacteriology 92 (1966), 477–486.